Genuit Group PLC (LSE:GEN)

£ 4.055 0.01 (0.25%) Market Cap: 1.01 Bil Enterprise Value: 1.16 Bil PE Ratio: 43.69 PB Ratio: 1.65 GF Score: 74/100

Half Year 2024 Genuit Group PLC Earnings Call Transcript
Aug 13, 2024

£4.44 (-4.62%)

Earnings
Full Year 2023 Genuit Group PLC Earnings Presentation Transcript
Mar 12, 2024
Half Year 2023 Genuit Group PLC Earnings Call Transcript
Aug 15, 2023

£3.06 (+0.99%)

Earnings
Full Year 2022 Genuit Group PLC Earnings Call Transcript
Mar 14, 2023

£2.62 (-6.26%)

Earnings
Genuit Group PLC Corporate Analyst Meeting Transcript
Nov 23, 2022
Half Year 2022 Genuit Group PLC Earnings Call Transcript
Aug 16, 2022

£4.2 (-0.12%)

Earnings
Full Year 2021 Genuit Group PLC Earnings Call Transcript
Mar 15, 2022

£4.93 (-2.95%)

Earnings
Half Year 2021 Genuit Group PLC Earnings Call Transcript
Aug 17, 2021

£6.61 (+2.01%)

Earnings
Full Year 2020 Polypipe Group PLC Earnings Call Transcript
Mar 16, 2021

£5.74 (+2.68%)

Earnings
London Topco Ltd, Polypipe Group plc - M&A Call Transcript
Feb 11, 2021
Polypipe Group PLC Corporate Analyst Meeting Transcript
Nov 17, 2020
Half Year 2020 Polypipe Group PLC Earnings Call Transcript
Sep 15, 2020

£4.25 (+4.17%)

Earnings
Half Year 2019 Polypipe Group PLC Earnings Call Transcript
Aug 13, 2019

£3.97 (-1.69%)

Earnings
Full Year 2018 Polypipe Group PLC Earnings Call Transcript
Mar 19, 2019

£4.05 (-6.38%)

Earnings

London Topco Ltd, Polypipe Group plc - M&A Call Transcript

Feb 11, 2021 / 08:30AM GMT

Release Date Price: £5.7 (+10.89%)

Transcript

Martin K. Payne

Polypipe Group plc - CEO & Executive Director

Good morning, everybody. Thanks for making the time to join us. We're going to talk about the acquisition of ADEY, which we're very excited about. But just before we do that, I should just frame where we are with the wider Polypipe business. So [Isabella], if we could just turn to Slide 4, please.

I think Polypipe is well positioned for the future. I think we've managed our way through the COVID crisis very well. As you know, we took significant actions to strengthen our balance sheet and increase financial flexibility back in May last year, and that's allowed us to continue investing in some of those key strategic growth projects that we talked about then. Most notably Safe Haven, if you remember, that's the ultraviolet filter in ventilation systems that will kill viruses. That got launched at the back end of the year and is doing extremely well, and we're very excited about that.

And in more general trading, consistent with the update that we gave on the 2nd of February, trading continued to recover well towards the

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.